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Summary: The Cancer Genome Atlas (TCGA) promises to transform the treatment of patients with cancer by identifying new drug targets. However, extracting mechanistically insightful, therapeutically actionable information from complex multidimensional datasets remains a signifi cant challenge. In this issue of Cancer Discovery, Genovese and colleagues apply a context-dependent modeling algorithm to the glioblastoma TCGA datasets and couple it with functional genetic screens and experimental validation to identify a novel, and potentially targetable, microRNA-mediated regulatory pathway. Cancer Discov; 2 (8) ; 676-8. ©2012 AACR.
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cally meaningful disease subsets (8) . MiRs can signifi cantly impact regulatory networks and can exert control over gene expression indirectly through regulation of transcription factors. This amplifi es/expands the number of genes regulated by miR expression and can drive tumorigenesis.
Most current approaches for identifying miR targets and regulatory networks involve sequence-based computational methods to predict physical association. Such approaches to identify miR-mRNA connections relevant to cancer are based on quantifi cation of linear dependencies between pairwise variables. Important functional regulatory relationships between pairwise variables, including miRs and mRNAs, may not be linear. Sequence prediction-based approaches miss a signifi cant number of critical regulatory interactions, which are mediated through indirect effects. MiR-regulated networks can be expanded by targeting transcription factors, chromatin modifi ers, molecules involved in signal transduction, and molecules involved in miR biogenesis and protein translation. Thus, integrating genetic context into nonlinear network models may shed light on functionally important regulatory interactions.
In this issue of Cancer Discovery, Genovese and colleagues (9) apply a Context Likelihood of Relatedness (CLR) network modeling algorithm to identify potentially signifi cant miR-mRNA pairs using data from 290 glioblastoma samples from TCGA. Integrative analyses using this method identifi ed a number of potentially signifi cant miR and mRNA interactions worthy of future study, a signifi cant proportion of which may be indirect. However, to further leverage the preexisting knowledge derived from TCGA and to assess the effect of genetic context on these regulatory networks, Genovese and colleagues (9) stratifi ed CLR-inferred global networks by glioblastoma molecular subtype, revealing that nearly 70% of the network edges involved miR and mRNA nodes differentially expressed between proneural and mesenchymal subtypes. This analysis yields a strong prediction that miR-mRNA regulation is likely an important determinant of the biologic phenotype of the proneural and mesenchymal glioblastoma subtypes.
Deeper analysis of predicted regulatory networks, focusing primarily on the proneural subtype, showed a potentially important role for miR-34a, which resides in a chromosomal region previously identifi ed by TCGA to be frequently lost in glioblastoma. To validate its potential biologic significance, Genovese and colleagues (9) used a mouse genetic model of proneural glioblastoma harboring a p53 and Pten deletion in neural stem cells and neural progenitors (10) . ;EGFR VIII/+ astrocytes. Thus, miR-34a is effective as a tumor suppressor in the proneural glioblastoma subtype. Initially, network analysis revealed a miR-34a-PDGFRA (platelet-derived growth factor receptor A) node in proneural glioblastoma, and in vitro experimentation validated PDGFRA as a direct target of miR-34a.
Interestingly, less than 1% of the miR-34a subnetwork was predicted to be direct, suggesting that the majority of the nodes within the miR-34a network were likely indirect resulting from modulation of transcriptional regulators. An unbiased screen for transcription factor-binding site enrichment at the promoters of CLR-inferred mRNA nodes identifi ed 3 transcription factors: PBX1, Smad4, and Myc. Because PBX1 was not expressed in the human or mouse glioblastoma model systems and because Myc has been described as a valid target of miR-34a, the authors experimentally examined the connection between miR-34a and Smad4. Providing critical functional relevance, Genovese and colleagues (9) show that miR-34a can regulate Smad4 expression and its downstream targets Id1/Id3 and they show that Smad4 expression is suffi cient to overcome the tumor-suppressive ability of miR-34a in the proneural glioblastoma model system. Thus, Genovese and colleagues (9) show the potential importance of miR-34a in the proneural subtype of glioblastoma through regulation of PDGFRA and Smad4/Id1/Id3.
The study raises a number of intriguing challenges for researchers aiming to extract biologically meaningful information about regulatory networks from multidimensional cancer genomic datasets. The study reveals the importance of context in mediating the biologic and clinical effects of a regulatory network. In this glioblastoma cohort, increased miR-34a expression correlated with shorter overall survival. This is in contrast to other studies reported for pancreatic and breast cancers, which showed a signifi cant association between increased expression of miR-34a and favorable prognosis. One conclusion that can be drawn from these disparate results is the critical nature of context in mediating the clinical effects of genetic and epigenetic changes in cancer-a theme likely to resonate in future studies. It is widely recognized that cell context-dependent effects may be important mediators of the impact of changes in miRs, as 3′UTRs can be modifi ed through alternative splicing, thus altering miR targets (11) . Well-annotated 3′UTRs may potentially provide valuable additional information toward understanding the biologic impact of changes in miR expression and for defi ning the prognostic value of miR expression in molecularly heterogeneous cancer subtypes. By showing that the majority of mRNA-miR interactions within glioblastoma are predominantly mediated through indirect mechanisms, including through modulation of transcriptional regulators targeted by a miR, this article raises an important challenge for application of sequence-based prediction algorithms and provides a complementary approach that may be of signifi cant value for regulatory network and novel target discovery. In summary, Genovese and colleagues (9) provide an important proof-of-concept showing the power of contextbased algorithms for in silico analysis of complex genomic datasets and highlight the importance of coupling such computational approaches with functional genetic screens and experimental validation to detect novel cancer regulatory networks and new therapeutic targets.
